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by M.C. Jones, Angela Noufaily and Kevin Burke
Abstract
We are concerned with the flexible parametric analysis of bivariate survival
data. Elsewhere, we have extolled the virtues of the “power generalized
Weibull” (PGW) distribution as an attractive vehicle for univariate parametric
survival analysis: it is a tractable, parsimonious, model which interpretably
allows for a wide variety of hazard shapes and, when adapted (to give an
adapted PGW, or APGW, distribution), covers a wide variety of important
special/limiting cases. Here, we additionally observe a frailty relationship
between a PGW distribution with one value of the parameter which con-
trols distributional choice within the family and a PGW distribution with a
smaller value of the same parameter. We exploit this frailty relationship to
propose a bivariate shared frailty model with PGW marginal distributions:
these marginals turn out to be linked by the so-called BB9 or “power variance
function” copula. This particular choice of copula is, therefore, a natural one
in the current context. We then adapt the bivariate PGW distribution, in
turn, to accommodate APGW marginals. We provide a number of theoretical
properties of the bivariate PGW and APGW models and show the potential of
the latter for practical work via an illustrative example involving a well-known
retinopathy dataset, for which the analysis proves to be straightforward to im-
plement and informative in its outcomes. The novelty in this article is in the
appropriate combination of specific ingredients into a coherent and successful
whole.
Keywords : BB9 copula; Gompertz; log-logistic; power variance frailty; shared
frailty.
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1. Introduction
In this article, we are concerned with the flexible parametric analysis of paired
survival data. Such data arise frequently in medicine, for example, when
comparing treatment and control on pairs of related sampling units such as
an individual’s eyes or limbs, or when measurements are made pre- and post-
intervention of some kind, or when familial data such as observations made on
twins or on a parent and child are of interest, and so on. Here, our concern is
with providing a flexible parametric model for the entire, correlated, bivariate
distribution of the pairs of outcomes. To do so, we reason for specific elements
and combine them into a new overall model in a coherent and successful way.
In Burke, Jones & Noufaily (2018; henceforth BJN), we argued, in the uni-
variate case, in favour of flexible parametric survival analysis in general and
for the use of an adapted form of an existing flexible parametric model called
the “power generalized Weibull” (PGW) distribution in particular. Advan-
tages of the latter include that its two shape parameters control key shapes
of the hazard function (constant, increasing, decreasing, up-then-down, down-
then-up, and no others) and that, when adapted, several common and impor-
tant survival distributions are special/limiting cases of it (log-logistic, Weibull,
Gompertz and others). The PGW distribution is one of only a very few to
parsimoniously and interpretably control hazard shapes as just described —
others include the generalized gamma (GG) and exponentiated Weibull (EW)
distributions — but it is preferred by us because of its extra tractability and
its greater breadth of particular cases.
In this article, we also take advantage of a further feature of the PGW dis-
tribution not shared with GG or EW distributions. Inter alia, in Section 2.1,
we obtain a frailty relationship between a PGW distribution with one value of
the parameter κ which controls specific distributional choice within the PGW
family and a smaller value of the same parameter. We then exploit this frailty
relationship and first pursue — in Section 3 — a natural extension of the
PGW distribution, to the multivariate case in principle, but more specifically,
for convenience and many practical applications, to the bivariate case, through
the shared frailty route. In Section 4, we build on the work of Section 3 to
provide a closely related bivariate distribution with adapted PGW (APGW)
marginals, which is the version that we suggest for practical work, as exem-
plified in Section 5. The distribution has eight basic parameters, and these
can be extended in natural ways to accommodate covariates. Even so, the
model proves to be straightforward to implement using maximum likelihood
techniques, and to provide interpretable and insightful analysis of the example
on which we illustrate the methodology.
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In more detail, we first provide the relevant univariate background in Section
2, including the univariate frailty result that drives the remainder of the pa-
per in Section 2.1. The bivariate PGW distribution of interest in this article
is then developed in Section 3.1: its conditional hazard functions are consid-
ered in Section 3.2, its cross ratio dependence function in Section 3.3, and its
copula representation, and properties ensuing therefrom, in Section 3.4. Af-
ter explaining why we cannot follow the same shared frailty approach for the
APGW distribution as we do for the PGW distribution, we propose a bivariate
APGW distribution by transforming PGW marginal distributions to APGW
marginal distributions, retaining the same copula; see Section 4.1. Properties
other than those solely dependent on the copula, which are the same for both
bivariate PGW and APGW distributions, are considered in Section 4.2. We
provide an illustrative example of the application of the APGW distribution
to a standard, retinopathy, dataset in Section 5, first without its covariate
(Section 5.1) and then with the inclusion of the covariate (Section 5.2). In
particular, we observe how much the choice of marginal distributions impacts
on the degree of dependence of the bivariate failure model. We conclude the
article with brief further discussion in Section 6.
As the reader will observe, the distributions of interest in this article retain
the high degree of tractability of their univariate counterparts.
2. Univariate background
Write PGW(γ, κ, λ) for the PGW distribution with power parameter γ > 0,
distribution-choosing parameter κ > 0 and vertical scale/proportional hazards
(PH) parameter λ > 0. That is, it has cumulative hazard function (c.h.f.)
λHN(t; γ, κ) = λ {(1 + tγ)κ − 1} .
In practice, it is also important to consider a horizontal scale/accelerated fail-
ure time (AFT) parameter φ > 0 which enters the c.h.f. via λHN(φt; γ, κ); for
theoretical purposes, we can set φ = 1 without loss of generality. The PGW
distribution was first introduced by Bagdonavic¸ius & Nikulin (2002) (see also
Nikulin & Haghighi, 2009), independently re-introduced by Dimitrakopoulou,
Adamidis & Loukas (2007), and recognised as an interesting competitor to the
GG and EW distributions in Jones & Noufaily (2015).
The shape parameters γ and κ control the ‘head’ (values near zero) and tail of
the distribution in the sense that the hazard function hN(t; γ, κ) = H
′
N(t; γ, κ)
behaves as tγ−1 as t→ 0 and as tγκ−1 as t→∞. This allows a hazard function
with a zero, finite or infinite value at its head and likewise, independently, at its
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tail. What is more, the hazard function joins head to tail in a smooth manner
which yields a decreasing hazard when γ ≤ 1 and κγ ≤ 1, an increasing hazard
when γ ≥ 1 and κγ ≥ 1, an up-then-down (often called ‘bathtub’) hazard
when γ ≥ 1 and κγ ≤ 1, and a down-then-up (sometimes called ‘upside-down
bathtub’) hazard when γ ≤ 1 and κγ ≥ 1. If γ = κ = 1, the hazard function
is constant (the PGW distribution is then the exponential distribution).
BJN principally work with an adapted form of the PGW distribution, written
APGW(γ, κ, λ); this has as its c.h.f. a horizontally and vertically rescaled form
of the basic PGW c.h.f.:
λHA(t; γ, κ) = λ
(
κ+ 1
κ
){(
1 +
tγ
κ+ 1
)κ
− 1
}
.
Here, γ, λ > 0 and φ = 1 as before, but the domain of κ can be extended (if
desired) from κ > 0 to κ > −1; this affords a cure model when −1 < κ < 0,
in which the ‘improper’ survival function tends to exp{λ(κ+1)/κ} as t→∞.
Of course, when κ > 0, hazard function shapes, as described above for hN , are
unaffected.
When κ = 1, (A)PGW distributions are Weibull distributions; when κ = 2,
γ = 1, they are linear hazard distributions. The reason for switching from HN
to HA is that HA readily accommodates limiting cases, which also turn out
to be important and popular survival models: κ = 0 corresponds to the Burr
Type XII distribution which incorporates the log-logistic distribution when
λ = 1; and when κ → ∞, the PGW distribution tends to a form sometimes
called the ‘Weibull extension’ model which, for γ = 1, is the Gompertz dis-
tribution. The APGW distribution therefore affords, by choice of κ, a wide
range of popular survival models, from light-tailed Gompertz, through the
ubiquitous Weibull, to the heavy-tailed log-logistic, and ‘beyond’ to certain
cure models.
2.1 Frailty links
Frailty is usually introduced into survival models by mixing over the distribu-
tion of the proportionality parameter B say (Hougaard, 2000, Duchateau &
Janssen, 2008, Wienke, 2011). A given survival distribution can be produced
from another given survival distribution by such frailty mixing if the ratio
of their hazard functions is decreasing (Gupta & Gupta, 1996). Thus, when
PGW(γ, κ, B) is mixed with a certain frailty distribution, PGW(γ, ωκ, λ)
for 0 ≤ ω ≤ 1 and appropriate λ > 0 results. Notice that the frailty mix-
ing ‘moves us down’ from a PGW distribution with parameter κ to a PGW
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distribution with (the same value of γ and) smaller parameter ωκ. The fol-
lowing result identifies the mixing distribution. It is a tempered stable (TS),
or power variance distribution (Tweedie, 1984, Hougaard, 1986, 2000, Fischer
& Jakob, 2016). This distribution has three parameters, 0 ≤ ω ≤ 1, ξ > 0 and
θ ≥ 0. However, we will take θ = 1 throughout and refer to the corresponding
distribution as TS(ω, ξ). It is defined through its Laplace transform given by
Lω,ξ(s) = exp [ξ {1− (1 + s)ω} /ω] .
Result 1. Let T |B = b ∼ PGW(γ, κ, b) and let B ∼ TS(ω, ωλ). Then,
T ∼ PGW(γ, ωκ, λ).
Proof. Denote by gω,ξ the density of TS(ω, ωλ). Then,
P (T ≥ t) =
∫
∞
0
exp{−bHN(tγ ; κ)}gω,ωλ(b) db = Lω,ωλ{HN(tγ; κ)}
= exp (λ [1− (1 + tγ)κω]) = exp {−λHN(tγ ;ωκ)} . 
Some interesting special cases of Result 1 are that:
• ω = 1/2: if T |B = b ∼ PGW(γ, κ, b) and B follows the inverse Gaussian
distribution with parameters (1/2, 1/2), then T ∼ PGW(γ, κ/2, 1);
• ω = 0: if T |B = b ∼ PGW(γ, κ, b) and B follows the unit-scale gamma
distribution with shape parameter ξ, then T follows the Burr Type XII
distribution with power parameter γ and proportionality parameter ξκ.
(When κ = 1, this is the well known result that a Weibull distribution
with gamma frailty results in the Burr Type XII distribution.)
A related frailty link between the κ = ∞ and κ = 1 adapted PGW distribu-
tions is:
• if T |B = b has c.h.f. b(etγ −1) and B follows the exponential distribution
with parameter 1, then T follows the Weibull distribution.
There is a similar, if more complicated, frailty mixing result for the APGW
distribution but, because the mixing distribution then depends on κ, this
proves not to be so convenient for extension to the bivariate case. (It is included
in Appendix A for completeness.) Instead, we make our bivariate extension
based on the original PGW distribution and then change the marginals to
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APGW distributions, retaining the dependence structure associated with the
PGW-based extension.
3. The bivariate shared frailty PGW model
3.1 The model
In the bivariate case, suppose that, for i = 1, 2, Ti|B = b ∼ PGW(γi, κi, b)
independently and B ∼ TS(ω, ωλ) with λ > 0 and 0 ≤ ω ≤ 1. This is a shared
frailty model: given the single, shared, frailty random variable B = b, the
survival times are (conditionally) independent; the shared frailty introduces
the dependence, and this dependence is necessarily positive except for the
special case of independence (Hougaard, 2000, Duchateau & Janssen, 2008,
Wienke, 2011). In this case, T1 and T2 are (marginally) independent when
ω = 1, because then TS(1, λ) reduces to a point mass at λ.
The bivariate survival function can be obtained through an extension of the
proof of Result 1. Denote by gω,ωλ the density of TS(ω, ωλ). Then,
SN (t1, t2) ≡ P (T1 ≥ t1, T2 ≥ t2)
=
∫
∞
0
P (T1 ≥ t1; γ1, κ1, b)P (T2 ≥ t2; γ2, κ2, b) gω,ωλ(b) db
=
∫
∞
0
exp [−b {HN(t1; γ1, κ1) + bHN(t2; γ2, κ2)}] gω,ωλ(b) db
= Lω,ωλ {HN(t1; γ1, κ1) +HN (t2; γ2, κ2)}
= exp (λ [1− {(1 + tγ11 )κ1 + (1 + tγ22 )κ2 − 1}ω]) .
The univariate marginals are, of course, T1 ∼ PGW(γ1, ωκ1, λ) and T2 ∼
PGW(γ2, ωκ2, λ), by construction. This suggests reparametrising by τi = ωκi,
i = 1, 2, in which case
SN(t1, t2) = exp [λ {1− LωN (t1, t2)}] (1)
where
LN(t1, t2) ≡ (1 + tγ11 )τ1/ω + (1 + tγ22 )τ2/ω − 1, (2)
so that T1 ∼ PGW(γ1, τ1, λ), T2 ∼ PGW(γ2, τ2, λ) and ω and λ control the de-
pendence between T1 and T2. This is the bivariate model with PGW marginals
of interest in this article.
Just once, we mention the multivariate analogue of a result, namely
P (T1 ≥ t1, ..., Tp ≥ tp) = exp
(
λ
[
1−
{
p∑
i=1
(1 + tγii )
τi/ω − (p− 1)
}ω])
.
6
in order to remind the reader that a multivariate version of our bivariate
development is possible, if desired. Indeed, if τ1 = τ2 = ω in (1), this is a special
case (his κ = 1) of the “multivariate distribution with Weibull connections” of
Crowder (1989). Its bivariate form is SN ;C(t1, t2) = exp
[
λ
{
1− LωN ;C(t1, t2)
}]
where LN ;C(t1, t2) ≡ tγ11 + tγ22 + 1.
3.2 Conditional hazard functions
Returning to the bivariate case, all joint and conditional density, survival and
hazard functions are available in closed form. We will explicitly look at two
conditional distributions. For ease of notation, write K(t2) = (1+t
γ2
2 )
τ2 . Then,
it is immediate from (1) that a first conditional survival function is
P (T1 ≥ t1|T2 ≥ t2) = eλK(t2) exp {−λLωN (t1, t2)}
and the associated conditional c.h.f. is H(t1|T2 ≥ t2) = λ {LωN (t1, t2)−K(t2)} .
Writing
L10N (t1, t2) = ∂LN (t1, t2)/∂t1 = γ1τ1t
γ1−1
1 (1 + t
γ1
1 )
(τ1/ω)−1/ω,
the conditional hazard function
h(t1|T2 ≥ t2) = λωLω−1N (t1, t2)L10N (t1, t2) (3)
is seen to behave as tγ1−11 as t1 → 0 and as tγ1τ1−11 as t1 → ∞, a property
shared with the marginal hazard function to which h(t1|T2 ≥ t2) corresponds
when t2 = 0. Now,
h′(t1|T2 ≥ t2) = λωLω−2N (t1, t2)
[
(ω − 1){L10N (t1, t2)}2 + LN(t1, t2)L20N (t1, t2)
]
(4)
where
L20N (t1, t2) = ∂
2LN (t1, t2)/∂t1∂t2
= γ1τ1t
γ1−2
1 (1 + t
γ1
1 )
(τ1/ω)−2
{
γ1 − 1 +
(γ1τ1
ω
− 1
)
tγ11
}
/ω.
It then follows that h′(t1|T2 ≥ t2) is equal to positive terms times{
(1 + tγ22 )
τ2/ω − 1}{γ1 − 1 + (γ1τ1
ω
− 1
)
tγ11
}
+ (1 + tγ11 )
τ1/ω {γ1 − 1 + (γ1τ1 − 1) tγ11 } .
When t2 > 0, all we can guarantee is that
if γ1 ≥ 1 and γ1τ1 ≥ 1 then h(t1|T2 ≥ t2) is increasing,
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corresponding to the t2 = 0 case, and
if γ1 ≤ 1 and γ1τ1 ≤ ω then h(t1|T2 ≥ t2) is decreasing,
a more restricted parameter range than in the marginal case. Otherwise, we
cannot guarantee no more complicated shapes than in the t2 = 0 case even
though the hazards start and end up with the same behaviour whatever the
value of t2.
Another conditional survival function is
P (T1 ≥ t1|T2 = t2) = K(1/ω)−1(t2) eλK(t2) Lω−1N (t1, t2) exp {−λLωN (t1, t2)}
= K(1/ω)−1(t2)L
ω−1
N (t1, t2)P (T1 ≥ t1|T2 ≥ t2).
It follows that
h(t1|T2 = t2) = h(t1|T2 ≥ t2) + (1− ω)L10N (t1, t2)/LN (t1, t2), (5)
which has the same limiting behaviour as h(t1|T2 ≥ t2) given by (3). Also,
h′(t1|T2 = t2) = h′(t1|T2 ≥ t2) + (1− ω){LN(t1, t2)}−2
× [LN(t1, t2)L20N (t1, t2)− {L10N (t1, t2)}2] . (6)
The term in square brackets is equal to positive terms times{
(1 + tγ22 )
τ2/ω − 1}{γ1 − 1 + (γ1τ1
ω
− 1
)
tγ11
}
+ (1 + tγ11 )
τ1/ω (γ1 − 1− tγ11 ) .
When t2 > 0, we can only be sure that, just as for the other conditional hazard
function,
if γ1 ≤ 1 and γ1τ1 ≤ ω then h(t1|T2 = t2) is decreasing.
There is, however, no simple guarantee of increasingness.
3.3 Clayton’s cross ratio dependence function
Arguably the most important measure of pointwise dependence for bivariate
survival distributions is the Clayton (1978) cross ratio dependence function,
one of whose formulations is
θ(t1, t2) =
h(t1|T2 = t2)
h(t1|T2 ≥ t2)
8
(see also Oakes, 1989, Hougaard, 2000, Duchateau & Janssen, 2008). Recall
that, loosely speaking, positive (pointwise) dependence corresponds to values
of θ(t1, t2) > 1. Then, from formulae in Section 3.2,
θN(t1, t2) = 1 +
1− ω
λω
1
{LN(t1, t2)}ω = 1 +
1− ω
ω
1
λ− log SN(t1, t2) . (7)
For each t1 and t2, as λ increases, θN (t1, t2) decreases through values greater
than 1, with limλ→∞ θN (t1, t2) = 1; the latter corresponds to an uninteresting
degenerate independence case. Clearly, in the non-degenerate independence
case when ω = 1 (with proper PGW marginals), we have θN(t1, t2) = 1. It
can also be proved that θN(t1, t2) decreases with ω ∈ (0, 1), again through
values greater than 1. To this end, write ri = (1 + t
γi
i )
τi , i = 1, 2, so that
LN(t1, t2) = r
1/ω
1 + r
1/ω
2 − 1. Then we need the derivative with respect to ω of
(1− ω)/[ω{LN(t1, t2)}ω] which is a positive quantity times
−1− ω(1− ω)
{
log(r
1/ω
1 + r
1/ω
2 − 1)−
(r
1/ω
1 log r1 + r
1/ω
2 log r2)
ω(r
1/ω
1 + r
1/ω
2 − 1)
}
.
The term in curly brackets can be seen to be positive by consideration of
the function (a1 + a2 − 1) log(a1 + a2 − 1) − a1 log a1 − a2 log a2 to which
the term is proportional when ai = r
1/ω
i , i = 1, 2. But min{a1, a2} > 1
and, by differentiation, the function is increasing in a1 and a2. It therefore
tends to its infimum value when a = b = 1, and this infimum value is zero.
The derivative is therefore negative, and the Clayton cross ratio dependence
function decreases in ω for all t1, t2, as suggested.
3.4 The survival copula
Dependence in the bivariate PGW distribution can also be understood through
its survival copula. This is the cumulative distribution function (c.d.f.) defined
by
Ĉ(u, v) = SN(S
−1
1,N(u), S
−1
2,N(v)), 0 < u, v < 1,
with uniformly distributed marginals; here, Si,N is the ith marginal survival
function, i = 1, 2. It is easily seen that in this case
Ĉ(u, v) = exp
[
λ− {(λ− log u)1/ω + (λ− log v)1/ω − λ1/ω}ω] . (8)
(Survival function (1) is reconstructed from (8) as Ĉ(S1,N(t1), S2,N(t2)).)
This is a well known, Archimedean, copula. It is the BB9 copula of Joe (1997,
2015), also known as the PVF (power variance function) copula (Hougaard,
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2000, Duchateau & Janssen, 2008, Romeo, Meyer & Gallardo, 2018). Of
course, ω = 1 corresponds to the case of independence (Ĉ(u, v) = uv) while as
ω → 0, Ĉ(u, v)→ min(u, v), the Fre´chet upper bound (equivalent to T1 = T2).
We also have independence as λ → ∞. When λ = 1, the BB9/PVF copula
reduces to copula (4.2.13) of Nelsen (2006) while, as λ → 0, it tends to the
Gumbel copula
ĈG(u, v) = exp
[
−{(− log u)1/ω + (− log v)1/ω}ω] .
The novelty in this article is that we naturally use the BB9/PVF copula
— as opposed to any other arbitrarily chosen copula — in conjunction with
PGW marginal distributions — as opposed to any other arbitrarily chosen
marginals — because univariate PGW distributions are closed under tempered
stable/power variance frailty distributions.
Concordance, or positive quadrat dependence, is a strong positive dependence
property that implies many others (for instance, if concordance increases, so do
Kendall’s tau, Spearman’s rho, and tail dependence). Joe (2014) shows that,
for the BB9/PVF copula, concordance increases as either ω or λ decreases.
We will briefly investigate some more specifics of the behaviour of Kendall’s
tau, K say, and Spearman’s rho, S say, as functions of ω and λ.
A bivariate Archimedean copula is of the form φ{φ−1(u)+φ−1(v)} where φ is a
survival function on R+ associated with a decreasing density. For BB9/PVF,
φ(s) = exp [λ {1− (1 + s)ω}] and
K = 1− 4
∫
∞
0
s{φ′(s)}2ds
= 1− ω {1 + 2λ− (2λ)1/ωe2λ Γ(2− (1/ω), 2λ)}
where Γ(a, z) =
∫
∞
z
xa−1e−x dx is an incomplete gamma function (for alter-
native versions of this formula, see (7.58) of Hougaard (2000) and (4.87) of
Duchateau & Janssen, 2008). K decreases from 1 (Fre´chet copula) towards 0
(independence) as ω increases from 0 to 1 and from 1 − ω (Gumbel copula)
towards 0 (independence) as λ increases from 0 without bound. (It is easy to
confirm that K ≤ 1−ω for all λ > 0, 0 ≤ ω ≤ 1 using a standard inequality for
the incomplete gamma function which is a simple consequence of integration
by parts.) The behaviour of K is confirmed in Figure 1 which is a contour
plot of K as a function of ω (horizontal axis) and λ (vertical axis).
There is no such similar explicit form for Spearman’s rho for Archimedean
copulas in general or the BB9/PVF copula in particular, but a numerically-
derived graphical representation of it for BB9/PVF as a function of ω and λ
10
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Figure 1: Kendall’s tau plotted as a function of 0 ≤ ω ≤ 1 and λ > 0 (curtailed
at λ = 10) for the BB9/PVF copula.
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Figure 2: Spearman’s rho plotted as a function of 0 ≤ ω ≤ 1 and λ > 0
(curtailed at λ = 10) for the BB9/PVF copula.
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is also of interest; see Figure 2. The qualitative features of Figure 2 are very
similar to those of Figure 1: S too decreases from 1 (Fre´chet copula) towards 0
(independence) as ω increases from 0 to 1 and from a positive value (Gumbel
copula) towards 0 (independence) as λ increases from 0 without bound. It is
also suggested that S ≥ K for the BB9/PVF copula, but we have no proof.
An upper bound for S for the Gumbel copula, and hence for the BB9/PVF
copula, is
S ≤ min
[
3
{
22(2−ω)
(1 + 21−ω)2
− 1
}
, 1
]
. (9)
The bound is non-trivial for ω > 1+ log2(
√
3− 1) ≃ 0.55. See Appendix B for
proof of this.
4. The bivariate APGW model
4.1 The model
We cannot simply replace the steps taken for the original PGW distribution
for the adapted PGW distribution despite the existence of a parallel frailty
result for APGW distributions in Result A1 in Appendix A: in Result A1,
the TS distribution depends on κ, so the frailty distribution involved is not a
single one to be shared by each failure time.
There is, however, a (still tractable) alternative which is to transform each
marginal random variable, Ti, currently following an ordinary PGW(γi, τi, λ)
distribution to one, Zi say, following an APGW(γi, τi, λ) distribution, using
Zi =
[
(τ + 1)1−(1/τ) {1 + τ(1 + tγ)τ}1/τ − (τ + 1)
]1/γ
,
i = 1, 2. The resulting bivariate APGW distribution has survival function
SA(z1, z2) = exp [λ {1− LωA(z1, z2)}] (10)
where
LA(z1, z2) =
{
(τ1 + 1)
τ1
(
1 +
zγ11
τ1 + 1
)τ1
− 1
τ1
}1/ω
+
{
(τ2 + 1)
τ2
(
1 +
zγ22
τ2 + 1
)τ2
− 1
τ2
}1/ω
− 1. (11)
Of course, this is nothing other than introducing APGW marginals instead
of PGW marginals into the BB9/PVF copula (8). (Survival function (10) is
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Ĉ(S1,A(z1), S2,A(z2)) where Si,A is the ith marginal APGW survival function,
i = 1, 2.)
Special and limiting cases include bivariate Weibull ((τ1, τ2) = (1, 1)), log-
logistic/Burr Type XII ((τ1, τ2)→ (0, 0)) and Gompertz distributions ((τ1, τ2)
→ (∞,∞)). Their survival functions are all of the form (10) with LA functions
given by
LA;W (z1, z2) = (1 + z
γ1
1 )
1/ω + (1 + zγ22 )
1/ω − 1,
LA;B(z1, z2) = {1 + log(1 + zγ11 )}1/ω + {1 + log(1 + zγ22 )}1/ω − 1
and
LA;G(z1, z2) = exp(z
γ1
1 /ω) + exp(z
γ2
2 /ω)− 1,
respectively.
Because the bivariate APGW distribution of this section has the same copula
as the bivariate PGW distribution of Section 2, all those aspects of dependence
that are encapsulated in the copula, and explored in Section 3.4, apply to the
bivariate APGW distribution in the same way as they do to the bivariate
PGW distribution.
4.2 Conditional hazard functions and Clayton’s cross ratio dependence function
The investigations of Sections 3.2 and 3.3, which are not purely copula-
dependent, need to be reworked for the bivariate APGW distribution. Be-
cause survival function (10) has the same form as survival function (1), the
conditional hazard functions and Clayton’s cross ratio dependence function
have the same form as before (3), (5) and (7), respectively, but with LA given
by (11) replacing LN given by (2).
The claims made for the bivariate APGW distribution in the remainder of
this section are based on formulae given in Appendix C. We find that for
h(z1|Z2 ≥ z2) we have:
if γ1 ≥ 1 and γ1τ1 ≥ 1 then h(z1|Z2 ≥ Z2) is increasing,
corresponding to the z2 = 0 case, and
if γ1 ≤ 1 and γ1 ≤ ω
1− ω + τ1 then h(z1|Z2 ≥ z2) is decreasing,
which is a little more restricted than in the bivariate PGW case. And also, in
the APGW case, we can only be sure that
if γ1 ≤ 1 and γ1 ≤ ω
1− ω + τ1 then h(x|Y = y) is decreasing
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but, as in the bivariate PGW case, there is no simple guarantee of positivity.
As trailed above, the cross ratio dependence function is now
θA(z1, z2) = 1 +
1
λ
(
1
ω
− 1
)
1
{LA(z1, z2)}ω .
Its monotonicity properties — decreasingness in λ and ω — remain as in the
PGW case. The latter now follows by the same argument as in Section 3.3
except with ri = [(τi + 1){1 + zγ1i /(τi + 1)}τi − 1]/τi, i = 1, 2.
5. Application
The well-known retinopathy dataset of Huster, Brookmeyer, and Self (1989;
henceforth HBS) (available in the survival package in R) consists of measure-
ments of the time to blindness in each of their eyes for 197 individuals. For
each individual, one eye was randomised to a laser treatment with the other
eye acting as a control and, hence, survival times are naturally paired within
individuals. The main focus of this study was to evaluate the effectiveness
of the treatment, that is, to compare aspects of the marginal survival distri-
butions (in the presence of dependence). However, a covariate indicating the
diabetes type (juvenile or adult at age of onset) was also of interest.
We use the bivariate APGW distribution to analyse these data, first without
the covariate (Section 5.1) and then with the addition of the covariate (Section
5.2). The ‘full’ bivariate APGW distribution that we consider is that of Section
4 with horizontal scale/AFT parameters added into each marginal, that is, the
model with survival function SA(φ1z1, φ2z2) where SA is given by (10) and (11).
This model has eight parameters:
(Z1, Z2) ∼ bivariate APGW( λ, ω,︸︷︷︸
dependence
φ1, γ1, τ1︸ ︷︷ ︸
Z1 marginal
, φ2, γ2, τ2︸ ︷︷ ︸
Z2 marginal
). (12)
However, for ease of optimisation in fitting models using maximum likelihood
estimation, we will prefer to work in terms of the vector of unconstrained
parameters, θ = (θλ, θω, θφ1 , θγ1 , θτ1 , θφ2 , θγ2 , θτ2)
T where
θλ = log λ, θω = log{ω/(1− ω)}, θφj = log φj,
θγj = log γj, θτj = log(τj + 1),
j = 1, 2. In the context of the retinopathy dataset, the index ‘1’ corresponds
to treatment and the index ‘2’ to control.
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5.1 Treatment effect (no covariate)
In this subsection, we consider a series of submodels of (12) investigating the
treatment effect (without including the diabetes covariate). Table 1 compares
the eight models arising from all combinations of the following constraints:
(i) common scale φ1 = φ2 = φ,
(ii) common power γ1 = γ2 = γ, and
(iii) common distribution τ1 = τ2 = τ ,
together with, as the first model, the unconstrained model. Each model has
been fitted to the data using maximum likelihood, implemented using a New-
ton procedure via the standard nlm optimiser in R.
Table 1: Comparison of treatment models
Model Common dim(θ) ℓ(θ) AIC BIC ∆AIC ∆BIC K
1 — 8 -824.24 1664.48 1690.74 2.36 8.93 0.24
2 φ 7 -824.62 1663.25 1686.23 1.13 4.41 0.28
3 γ 7 -824.64 1663.28 1686.27 1.17 4.45 0.24
4 τ 7 -824.71 1663.42 1686.40 1.30 4.59 0.18
5 φ, γ 6 -826.45 1664.91 1684.61 2.79 2.79 0.18
6 φ, τ 6 -826.01 1664.02 1683.72 1.90 1.90 0.19
7 γ, τ 6 -825.06 1662.12 1681.81 0.00 0.00 0.18
8 φ, τ, γ 5 -839.59 1689.19 1705.60 27.07 23.79 0.16
“Common” indicates which parameters (“pars”) are constrained to be equal,
ℓ(θ) is the log-likelihood value, ∆AIC = AIC−min(AIC), ∆BIC = BIC−min(BIC),
K is Kendall’s tau.
We see that both the AIC and BIC are considerably larger for Model 8 than for
any of the other fitted models. Model 8 is the model with equal distributions
for the treated and untreated groups; hence, there certainly appears to be
a difference between these groups. On the other hand, the full flexibility of
Model 1 with unconstrained parameters appears not to be required here. The
model with both the lowest AIC and BIC is Model 7 which has common shape
parameters, but different scales, that is, the basic distribution and shape of
hazard is the same for these two treatment groups, but they have different
scales; Figure 3 reveals that the fit to the data is excellent.
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Figure 3: Kaplan–Meier (step) curves with model-based curves (smooth) over-
laid for Model 7 of Table 1.
Table 2 displays parameter estimates for Model 7. As the two treatment
groups here differ only with respect to their horizontal scale, we have the AFT
property across groups. Thus, the quantile ratio is given by ψ = exp(θφ2−θφ1)
which is estimated as ψˆ = 2.84, that is, time to blindness is almost 3 times
longer in eyes that receive laser treatment than in those that do not; the
corresponding 95% confidence interval is (1.64, 4.92) (calculated using the delta
method).
Table 2: Parameter estimates using Model 7
Parameter θλ θω θγ θτ θφ1 θφ2
Estimate −5.57 1.52 1.52 0.14 −0.07 0.98
(S.E.) (2.02) (0.40) (1.78) (0.23) (0.45) (0.62)
Parameters shown are in unconstrained form, for example, θλ = logλ.
φ1 and φ2 are the scale parameters for the treatment and control group, respectively.
Note that all models fitted in Table 1 indicate quite a low level of correlation as
measured by Kendall’s tau. In practice, however, it is often the case that the
marginal models are fixed, for example, to Weibull or Gompertz distributions.
In contrast, our more flexible APGW marginal distribution automatically se-
lects the marginal models via the τ parameter(s); the estimated (common) τ
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value in our model is 0.15, with 95% confidence interval (−0.26, 0.78), which
does not support Weibull or Gompertz margins (τ = 1, τ =∞). Misspecified
marginal models have the potential to bias the measure of dependence. We
briefly investigate the effect of the marginal model on Kendall’s tau by starting
with Model 7 (of Table 2) and profiling over the τ parameter (including key
models such as log-logistic, Weibull and Gompertz). The results are shown in
Table 3 where we see that it is indeed the case that the value of K varies with
the choice of marginal model. In particular, the maximum likelihood marginal
model with τˆ = 0.15 yields a lower K value than that of other τ values. Hence,
fixing τ a priori has the potential to alter our view of the level of dependence.
Interestingly, a 95% confidence interval for K based on Model 7 is (0.08, 0.31).
While this covers all K values in Table 3 (just!), note from the Chi-squared
statistics of Table 3 that higher K values in models with Weibull or Gompertz
margins are not supported by the data.
Table 3: Profiling τ for Model 7
Model τ K ℓ(θ) χ21
Log-logistic 0.00 0.27 -826.89 3.66
0.07 0.18 -825.24 0.36
Model 7 0.15 0.18 -825.06 0.00
0.57 0.20 -826.74 3.36
Weibull 1.00 0.24 -829.03 7.94
1.23 0.27 -829.45 8.78
1.72 0.31 -829.60 9.09
Gompertz ∞ 0.31 -829.63 9.14
χ21 is the chi-squared statistic given by computing 2(ℓModel 7 − ℓτ0) where ℓModel 7
is the likelihood for Model 7, and ℓτ0 is the likelihood for τ fixed at τ0.
Note that the best-fitting treatment model of HBS is also one in which treat-
ment enters the scale but not the shape. Their model comprises Weibull
marginals together with a Clayton copula. It too has an AFT interpretation,
their estimated quantile ratio turning out to be 2.62, which is numerically sim-
ilar to our result. The AIC and BIC values for HBS’s model are, respectively,
1667.21 and 1680.34, that is, the AIC value is much higher than that of our
Model 7, while the BIC is slightly lower. The value ofK associated with HBS’s
best-fitting model is 0.30, which, in light of Table 3, may be somewhat high.
This could be a result of fixing to Weibull marginals or the use of a different
(one-parameter) copula. Thus, while our proposed model can adapt readily
to a variety of situations through its flexible copula and margins, the general
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use of simpler copula and marginal components will not work well in as many
cases.
5.2 Diabetes effect (added covariate)
From the previous subsection, there is clearly a difference between treatment
groups which manifests via a scale change rather than a shape change. It is
also of interest to discover whether or not the type of diabetes – “juvenile” (the
reference group here) or “adult” – is related to survival and, indeed, whether or
not the diabetes effect interacts with the treatment effect. We will investigate
this by extending the best treatment model from the previous section, Model
7, as follows:
θγ = θγ,0 + θγ,1D, θφ1 = θφ1,0 + θφ1,1D, θφ2 = θφ2,0 + θφ2,1D,
where D is the binary diabetes indicator such that D = 1 means that the
diabetes type is adult. Note that, in line with our previous work, we are
keeping the distributional parameter, τ , as a covariate-independent parameter.
Moreover, the copula parameters will also remain independent of the covariate
for the moment.
The above model set-up permits a diabetes effect which interacts with treat-
ment and, indeed, non-AFT effects via the inclusion of D into the power shape
parameter. We arrive at four models of interest characterized by combinations
of:
(i) D has a non-AFT effect (θγ,1 is free) or D has an AFT effect (θγ,1 = 0);
(ii) D interacts with treatment (θφ1,1 and θφ2,1 are free) or not (θφ1,1 =
θφ2,1 = 0).
These four models were fitted to the data using maximum likelihood, and the
results are summarised in Table 4. Model 7(b) has the lowest AIC and BIC
values. Hence, it appears that diabetes interacts with treatment, and can be
described by an AFT effect, that is, diabetes does not affect the shape of the
distribution. This is in line with the diabetes model considered by HBS —
although they did not investigate the potential shape effect of diabetes. We
can see from Figure 4 that Model 7(b) provides an excellent fit to the data.
An interesting finding is that, on the basis of BIC, the model without dia-
betes, the earlier Model 7, would be preferred to Model 7(b), whereas the
improvement upon accounting for treatment was clear (compare Models 7 and
8). This reflects the fact that the difference between treatment groups is larger
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Table 4: Comparison of treatment models with diabetes covariate
Model Diabetes Effect dim(θ) ℓ(θ) AIC BIC ∆AIC ∆BIC K
7(a) non-AFT int. 9 -820.86 1659.73 1689.28 0.38 3.67 0.19
7(b) AFT int. 8 -821.67 1659.35 1685.61 0.00 0.00 0.19
7(c) non-AFT 8 -822.74 1661.47 1687.74 2.13 2.13 0.17
7(d) AFT 7 -825.04 1664.08 1687.06 4.73 1.45 0.18
“int.” is short for “interaction”, ℓ(θ) is the log-likelihood value, ∆AIC = AIC−min(AIC),
∆BIC = BIC−min(BIC), K is Kendall’s tau.
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Figure 4: Kaplan–Meier (step) curves with model-based curves (smooth) over-
layed for Model 7(b) of Table 4
Table 5: Parameter estimates using Model 7(b)
Parameter θλ θω θγ θτ θφ1,0 θφ1,1 θφ2,0 θφ2,1
Estimate −4.90 1.40 0.99 0.22 −0.05 −0.58 0.55 0.42
(S.E.) (0.96) (0.37) (0.58) (0.11) (0.52) (0.35) (0.55) (0.28)
Parameters shown are in unconstrained form, for example, θλ = logλ.
φ1 and φ2 are the scale parameters for the treatment and control group, respectively.
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that the difference within treatment groups (via the diabetes type). On the
other hand, based on the AIC and BIC, the models with a common diabetes
effect would not be chosen over the treatment-only model (actually, Model
7(c) does have a very slightly lower AIC than Model 7 but this is not enough
to warrant selection of the more complex Model 7(c)). In other words, a com-
mon diabetes effect is not plausible. This is clear from Figure 4 where the
diabetes effect is reversed when comparing the treatment group to the control
group. Furthermore, we see from Table 5 — which gives parameter estimates
for Model 7(b) — that the diabetes effects within each group (θφ1,1 and θφ2,1,
respectively) have different signs.
We can readily quantify the treatment effect for those with juvenile and adult
diabetes in terms of quantile ratios. These are ψJ = exp(θφ2,0 − θφ1,0) and
ψA = exp{(θφ2,0 + θφ2,1) − (θφ1,0 + θφ1,1)}. Their estimates turn out to be
ψˆJ = 1.81, with 95% confidence interval (1.12, 2.91), and ψˆA = 4.94, with
95% confidence interval (2.71, 9.02), respectively. The conclusion is that time
to blindness is almost doubled for treated individuals with juvenile diabetes,
while the time to blindness is increased by a factor of almost five for treated
individuals with adult diabetes. (Similar point estimates of quantile ratios
arise from HBS’s model also.)
Finally, we also investigate whether or not covariate dependent copula param-
eters (λ and ω) might be needed. We therefore extended Model 7(b) (of Table
5) to have covariate dependent copula parameters. The resulting model (not
shown) has AIC and BIC values of 1662.51 and 1695.34, respectively, which
are both higher than those of Model 7(b). Moreover, the estimated K values
for D = 0 and D = 1 are respectively 0.19 and 0.20 which are numerically very
close to each other — and indeed to that of Model 7(b). Furthermore, the fit-
ted marginal models (not shown) are almost indistinguishable from those seen
in Figure 4. Therefore, here, covariate-dependent copula parameters are not
supported by the data, that is, Model 7(b) is sufficiently flexible. Of course,
in other settings the level of correlation may vary with covariates, and mod-
elling correlation on covariates in addition to the marginal distributions may
avoid model misspecification (again noting the effect on Kendall’s tau of the
marginal model as observed in Table 3).
6. Further remarks
In this article, we have proposed the novel combination of APGW marginal
distributions and the BB9/PVF copula. We have shown that this specific uni-
fication is very natural and effective, yielding a new bivariate model whose
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marginals include many of the most popular survival distributions (and, in-
deed, whose marginals may differ in type via separate τ parameters, as shown
in (12)). This flexibility, along with the variety of regression structures avail-
able, produces a very general overall modelling scheme which is useful in prac-
tice.
On the practical implementation of our model, it is worth highlighting that,
based on the findings of BJN, we would not require a model with both λi
and φi (a vertical scale parameter and a horizontal scale parameter, respec-
tively) appearing in the APGW marginal survival function Si,A(zi), i = 1, 2,
simultaneously, due to their similar roles. However, here, with λ1 = λ2 = λ,
where λ also controls dependence within Ĉ(u, v), we do not experience the is-
sue. It is possible that estimation instability may arise within the model when
φ1 = φ2 = φ particularly when ω is close to one as, in that case, λ plays little
role in characterising dependence and the margins then simply contain two
scale parameters, λ and φ. Of course, one could contemplate models where λ1
and λ2 are unconstrained (that is, λ1, λ2 6= λ) but, following BJN, we would
then consider either APGW(λi, φi = 1, γi, τi) or APGW(λi = 1, φi, γi, τi) mar-
gins.
Shared frailty models like the ones of interest in this article are sometimes
criticised on grounds of insufficient flexibility. A correlated frailty model is
an attractive alternative, but in order to obtain one in the current context it
is necessary to employ a defensible bivariate tempered stable/power variance
distribution for the frailties. We are not aware of such a bivariate TS/PV
model.
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Appendix A: Frailty Link for APGW Distribution
Write APGW(γ, κ, λ) for the adapted PGW distribution with proportionality
parameter λ > 0 and shape parameter κ i.e. with c.h.f. λHA(t
γ; κ). Also, write
the three-parameter version of the TS distribution as TS(ω, ξ, θ), 0 ≤ ω ≤ 1,
ξ > 0, θ ≥ 0, having Laplace transform
LHω,ξ,θ(s) = exp
[
− ξ
ω
{(θ + s)ω − θω}
]
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and density gHω,ξ,θ.
Result A1. Let T |B = b ∼ APGW(γ, κ, b), κ > 0, and let B ∼
TS
(
ω, κ
ω−1(ωκ+1)
(κ+1)ω
, κ+1
κ
)
. Then, aT ∼ APGW(γ, ωκ, 1) where a =
{(κ+ 1)/(ωκ+ 1)}1/γ.
Proof
ST (t) =
∫
∞
0
exp{−bHA(tγ ; κ)}gH
ω,
κω−1(ωκ+1)
(κ+1)ω
,κ+1
κ
(b) db
= LH
ω,
κω−1(ωκ+1)
(κ+1)ω
,κ+1
κ
{HA(tγ ; κ)}
= exp
[
−κ
ω−1(ωκ+ 1)
ω(κ+ 1)ω
×
{(
κ+ 1
κ
+
κ + 1
κ
{(
1 +
tγ
κ+ 1
)κ
− 1
})ω
−
(
κ+ 1
κ
)ω}]
= exp
[
−(ωκ+ 1)
ωκ
{(
1 +
tγ
κ + 1
)ωκ
− 1
}]
= exp
[
−HA
{(
t
a
)γ
;ωκ
}]
. 
Appendix B: Proof of (9)
For the Gumbel copula, S = 12 I − 3 where
I =
∫ 1
0
∫ 1
0
ĈG(u, v) dv du
=
∫ 1
0
∫ 1
0
exp
[
−{(− log u)1/ω + (− log v)1/ω}ω] dv du
=
∫
∞
0
∫
∞
0
e−(x+y) exp
{
− (x1/ω + y1/ω)ω} dy dx
≤
∫
∞
0
∫
∞
0
exp
{−(1 + 2ω−1)(x+ y)} dy dx
= 1/(1 + 2ω−1)2,
hence (9). Here, we have used the generalized mean inequality (x1/ω+y1/ω)ω ≥
2ω−1(x+ y) for 0 ≤ ω ≤ 1.
Appendix C: Formulae Underlying Claims in Section 4.2
From (11), we have
L10A (z1, z2) =
γ1
ω
zγ1−11
(
1 +
zγ11
τ1 + 1
)τ1−1{(τ1 + 1)
τ1
(
1 +
zγ11
τ1 + 1
)τ1
− 1
τ1
}(1/ω)−1
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and
L20A (z1, z2) =
γ1
ω τ1
zγ1−21
(
1 +
zγ11
τ1 + 1
)τ1−2{(τ1 + 1)
τ1
(
1 +
zγ11
τ1 + 1
)τ1
− 1
τ1
}(1/ω)−2
×
[{
(γ1 − 1)(τ1 + 1) +
(γ1 τ1
ω
− 1
)
zγ11
}(
1 +
zγ11
τ1 + 1
)τ1
−
{
γ1 − 1 + (γ1τ1 − 1)
τ1 + 1
zγ11
}]
.
Using these formulae in place of the equivalent formulae for LN in (4), we find
that h′(z1|Z2 ≥ z2) is equal to positive terms times[{
(τ2 + 1)
τ2
(
1 +
zγ22
τ2 + 1
)τ2
− 1
τ2
}1/ω
− 1
]
×
[{
(γ1 − 1)(τ1 + 1) +
(γ1 τ1
ω
− 1
)
zγ11
}(
1 +
zγ11
τ1 + 1
)τ1
−
{
γ1 − 1 + (γ1τ1 − 1)
τ1 + 1
zγ11
}]
(13)
+
{
(τ1 + 1)
τ1
(
1 +
zγ11
τ1 + 1
)τ1
− 1
τ1
}1/ω
×
[
{(γ1 − 1)(τ1 + 1) + (γ1 τ1 − 1) zγ11 }
(
1 +
zγ11
τ1 + 1
)τ1
−
{
γ1 − 1 + (γ1τ1 − 1)
τ1 + 1
zγ11
}]
from which the claims about the monotonicity properties of h(z1|Z2 ≥ z2)
in Section 4.2 follow. Similarly, the term in square brackets in the formula
(6) when LA replaces LN is equal to positive terms times a formula identical
to (13) except with the term ‘γ1τ1’ replaced by zero in its fifth line. This
sole difference is responsible for the conclusions in Section 4.2 concerning the
monotonicity of h(z1|Z2 = z2).
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